An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, after ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
Prostate cancer treatments are very effective. The five-year survival rate for an early-stage cancer is now over 99 percent. Yet these treatments leave behind side effects. Urinary incontinence, which ...
Final 2025 CDC data show a record-low U.S. fertility rate of 53.2 and a 7% drop in teen births. What the numbers mean for maternity care access. Ric Flair Hospitalized Following Tampa Fall Hours After ...
The patient was at a facility in Minneola, Florida, while the surgeon operated remotely from another facility ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results